Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121827
Published online Oct 15, 2026. doi: 10.4251/wjgo.121827
Published online Oct 15, 2026. doi: 10.4251/wjgo.121827
Figure 6 FBXO15 partially reversed the inhibitory effects of PARVA knockdown on malignant phenotypes of gastric cancer cells.
A: Colony formation assays with quantification; B: EdU staining images after FBXO15 overexpression in PARVA-silenced cells; C: Quantification of EdU-positive cells; D: Transwell migration and invasion assays with quantification; E: Wound-healing assays with quantification of wound closure. aP < 0.001. NS: Not significant; Pa: PARVA; Fb: FBXO15; OE: Overexpression.
- Citation: Lu X, Li J, Wang ML, Wang HZ, Li YX. PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling. World J Gastrointest Oncol 2026; 18(10): 121827
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121827.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121827